Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement - Reply

被引：1
|
作者：
Lacy, Martha Q. [1 ]
Rajkumar, S. Vincent [1 ]
机构：
[1] Mayo Clin, Coll Med, Myeloma Grp, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2007年 / 82卷 / 04期
关键词：
D O I：
10.4065/82.4.517
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [31] Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
    Narita, Kentaro
    Miura, Daisuke
    Tsushima, Takafumi
    Terao, Toshiki
    Kuzume, Ayumi
    Tabata, Rikako
    Takeuchi, Masami
    Matsue, Kosei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
    S Giralt
    E A Stadtmauer
    J L Harousseau
    A Palumbo
    W Bensinger
    R L Comenzo
    S Kumar
    N C Munshi
    A Dispenzieri
    R Kyle
    G Merlini
    J San Miguel
    H Ludwig
    R Hajek
    S Jagannath
    J Blade
    S Lonial
    M A Dimopoulos
    H Einsele
    B Barlogie
    K C Anderson
    M Gertz
    M Attal
    P Tosi
    P Sonneveld
    M Boccadoro
    G Morgan
    O Sezer
    M V Mateos
    M Cavo
    D Joshua
    I Turesson
    W Chen
    K Shimizu
    R Powles
    P G Richardson
    R Niesvizky
    S V Rajkumar
    B G M Durie
    Leukemia, 2009, 23 : 1904 - 1912
  • [33] Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
    Patriarca, Francesca
    Petrucci, Maria T.
    Bringhen, Sara
    Baldini, Luca
    Caravita, Tommaso
    Corradini, Paolo
    Corso, Alessandro
    Di Raimondo, Francesco
    Falcone, Antonietta
    Ferrara, Felicetto
    Morabito, Fortunato
    Musto, Pellegrino
    Offidani, Massimo
    Petrini, Mario
    Rizzi, Rita
    Semenzato, Gianpietro
    Tosi, Patrizia
    Vacca, Angelo
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (02) : 93 - 105
  • [34] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
    Shah, Nina
    Aiello, Jack
    Avigan, David E.
    Berdeja, Jesus G.
    Borrello, Ivan M.
    Chari, Ajai
    Cohen, Adam D.
    Ganapathi, Karthik
    Gray, Lissa
    Green, Damian
    Krishnan, Amrita
    Lin, Yi
    Manasanch, Elisabet
    Munshi, Nikhil C.
    Nooka, Ajay K.
    Rapoport, Aaron P.
    Smith, Eric L.
    Vij, Ravi
    Dhodapkar, Madhav
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [35] Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma
    Leng, Siyang
    Chen, Yizhen
    Tsai, Wei-Yann
    Bhutani, Divaya
    Hillyer, Grace C.
    Lim, Emerson
    Accordino, Melissa K.
    Wright, Jason D.
    Hershman, Dawn L.
    Lentzsch, Suzanne
    Neugut, Alfred I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 22 - 28
  • [36] Use of bisphosphonates in multiple myeloma patients in Denmark, 2005–2015
    Tina Bech Olesen
    Ina Trolle Andersen
    Anne Gulbech Ording
    Vera Ehrenstein
    Anouchka Seesaghur
    Carsten Helleberg
    Trine Silkjær
    Rohini K. Hernandez
    Daniela Niepel
    Niels Abildgaard
    Supportive Care in Cancer, 2021, 29 : 4501 - 4511
  • [37] Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis
    Visram, Alissa
    Rajkumar, S. Vincent
    Kapoor, Prashant
    Dispenzieri, Angela
    Lacy, Martha
    Gertz, Morie
    Buadi, Francis
    Hayman, Suzanne
    Dingli, David
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S24 - S24
  • [38] Erratum: The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
    M A Hussein
    F D Vrionis
    R Allison
    J Berenson
    S Berven
    E Erdem
    S Giralt
    S Jagannath
    R A Kyle
    S LeGrand
    R Pflugmacher
    N Raje
    S V Rajkumar
    R L Randall
    D Roodman
    D Siegel
    R Vescio
    J Zonder
    B G M Durie
    Leukemia, 2008, 22 : 1649 - 1649
  • [39] Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic
    Mir, Muhammad A.
    Kapoor, Prashant
    Kumar, Shaji
    Pandey, Shivlal
    Dispenzieri, Angela
    Lacy, Martha Q.
    Dingli, David
    Hogan, William
    Buadi, Francis
    Hayman, Suzanne
    Gandhi, Manish
    Gertz, Morie A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06): : 349 - 357
  • [40] Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Chanan-Khan, Asher
    Leung, Nelson
    Ludwig, Heinz
    Jagannath, Sundar
    Niesvizky, Ruben
    Giralt, Sergio
    Fermand, Jean-Paul
    Blade, Joan
    Comenzo, Raymond L.
    Sezer, Orhan
    Palumbo, Antonio
    Harousseau, Jean-Luc
    Richardson, Paul G.
    Barlogie, Bart
    Anderson, Kenneth C.
    Sonneveld, Pieter
    Tosi, Patrizia
    Cavo, Michele
    Rajkumar, S. Vincent
    Durie, Brian G. M.
    San Miguel, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4976 - 4984
12345